Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 15/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 14/20 | 0.56 |
| ▸ | TSHR | P16473 | 11/20 | 0.56 |
| ▸ | USP2 | O75604 | 10/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 9/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30049623 | 1.00 | CYP3A4 (0.56) | CYP3A4CYP2D6TSHRUSP2CYP1A2 | |
| SCHEMBL27161433 | 0.96 | CYP2D6 (0.48) | CYP3A4CYP2D6TSHRUSP2CYP1A2 | |
| SCHEMBL30050935 | 0.96 | CYP2D6 (0.48) | CYP3A4CYP2D6TSHRUSP2CYP1A2 | |
| SCHEMBL27162156 | 0.91 | CYP2D6 (0.62) | CYP3A4CYP2D6TSHRUSP2CYP1A2 | |
| SCHEMBL30050997 | 0.91 | CYP2D6 (0.62) | CYP3A4CYP2D6TSHRUSP2CYP1A2 | |
| SCHEMBL27162693 | 0.90 | CYP2D6 (0.53) | CYP3A4CYP2D6TSHRUSP2CYP1A2 | |
| SCHEMBL30049383 | 0.90 | CYP2D6 (0.53) | CYP3A4CYP2D6TSHRUSP2CYP1A2 | |
| SCHEMBL27162246 | 0.88 | CYP3A4 (0.43) | CYP3A4CYP2D6TSHRUSP2CYP1A2 | |
| SCHEMBL30050073 | 0.88 | CYP3A4 (0.43) | CYP3A4CYP2D6TSHRUSP2CYP1A2 | |
| SCHEMBL30050081 | 0.85 | CYP3A4 (0.58) | CYP3A4CYP2D6TSHRUSP2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240254115-A1 | New Pyridine-Sulfonamide Derivatives as Sigma Ligands | ACONDICIONAMIENTO TARRASENSE (ES) | 2024-08-01 | — | — | US | claimed |
| EP-4330248-A1 | PYRIDINE-SULFONAMIDE DERIVATIVES AS SIGMA LIGANDS | Acondicionamiento Tarrasense (ES) | 2024-03-06 | — | — | EP | claimed |
| US-20240254115-A1 | New Pyridine-Sulfonamide Derivatives as Sigma Ligands | ACONDICIONAMIENTO TARRASENSE (ES) | 2024-08-01 | — | — | US | disclosed |
| EP-4330248-A1 | PYRIDINE-SULFONAMIDE DERIVATIVES AS SIGMA LIGANDS | Acondicionamiento Tarrasense (ES) | 2024-03-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240254115-A1 | New Pyridine-Sulfonamide Derivatives as Sigma Ligands | SIGMAR1, TMEM97, OPRD1 | CYP3A4 497/4885CYP2D6 514/4885TSHR 540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.